We are live on ! Find out more
BL

Balentine LLC Portfolio holdings

AUM $2.48B
1-Year Est. Return 17.44%
This Fund
S&P 500
This Quarter Est. Return
+4.96%
1 Year Est. Return
+17.44%
3 Year Est. Return
+46.33%
5 Year Est. Return
+51.14%
10 Year Est. Return
+189.48%
AUM
$1.02B
AUM Growth
+$71M
Cap. Flow
+$25.8M
Cap. Flow %
2.52%
Top 10 Hldgs %
92.79%
Holding
621
New
116
Increased
174
Reduced
62
Closed
36

Top Buys

Rank Stock Value
1
ACWI icon
iShares MSCI ACWI ETF
ACWI
+$9.24M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$5.06M
3
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$3.79M
4
QCOM icon
Qualcomm
QCOM
+$1.79M
5
VONV icon
Vanguard Russell 1000 Value ETF
VONV
+$1.4M

Top Sells

Rank Stock Value
1
VTR icon
Ventas
VTR
+$438K
2
WY icon
Weyerhaeuser
WY
+$424K
3
REG icon
Regency Centers
REG
+$352K
4
IDXX icon
Idexx Laboratories
IDXX
+$266K
5
BFH icon
Bread Financial
BFH
+$251K

Sector Composition

Rank Sector Weight
1 Technology 2.35%
2 Financials 1.49%
3 Consumer Staples 1.44%
4 Energy 1.34%
5 Industrials 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IT icon
426
Gartner
IT
$9.41B
$9K ﹤0.01%
+82
New +$8.45K
KMI icon
427
Kinder Morgan
KMI
$73.1B
$9K ﹤0.01%
434
– –
LBRDK icon
428
Liberty Broadband Class C
LBRDK
$4.15B
$9K ﹤0.01%
102
– –
MLR icon
429
Miller Industries
MLR
$586M
$9K ﹤0.01%
350
– –
NBR icon
430
Nabors Industries
NBR
$1.23B
$9K ﹤0.01%
14
+4
+40% +$3.06K
PBI icon
431
Pitney Bowes
PBI
$2.42B
$9K ﹤0.01%
662
+10
+2% +$141
BMRN icon
432
BioMarin Pharmaceuticals
BMRN
$11.5B
$8K ﹤0.01%
87
+42
+93% +$3.74K
DPZ icon
433
Domino's
DPZ
$11B
$8K ﹤0.01%
+42
New +$7.52K
DXCM icon
434
DexCom
DXCM
$27.6B
$8K ﹤0.01%
356
-28
-7% -$547
MELI icon
435
Mercado Libre
MELI
$91.3B
$8K ﹤0.01%
39
-6
-13% -$1.18K
TEVA icon
436
Teva Pharmaceuticals
TEVA
$35.9B
$8K ﹤0.01%
264
-73
-22% -$2.49K
UAA icon
437
Under Armour
UAA
$3B
$8K ﹤0.01%
419
– –
ULTA icon
438
Ulta Beauty
ULTA
$20.4B
$8K ﹤0.01%
27
+14
+108% +$3.83K
WEC icon
439
WEC Energy
WEC
$37.7B
$8K ﹤0.01%
132
+99
+300% +$5.83K
ICPT
440
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$8K ﹤0.01%
74
– –
ANDV
441
DELISTED
Andeavor
ANDV
$8K ﹤0.01%
+100
New +$8.38K
SPLS
442
DELISTED
Staples Inc
SPLS
$8K ﹤0.01%
889
+12
+1% +$108
ADI icon
443
Analog Devices
ADI
$181B
$7K ﹤0.01%
+86
New +$6.75K
AYI icon
444
Acuity Brands
AYI
$9.88B
$7K ﹤0.01%
36
+11
+44% +$2.32K
BW icon
445
Babcock & Wilcox
BW
$1.43B
$7K ﹤0.01%
76
-25
-25% -$3.5K
GIS icon
446
General Mills
GIS
$19.2B
$7K ﹤0.01%
122
-505
-81% -$30.9K
INCY icon
447
Incyte
INCY
$23.5B
$7K ﹤0.01%
52
– –
LOPE icon
448
Grand Canyon Education
LOPE
$3.71B
$7K ﹤0.01%
+95
New +$5.9K
MO icon
449
Altria Group
MO
$122B
$7K ﹤0.01%
1,103
+104
+10% +$7.53K
MSI icon
450
Motorola Solutions
MSI
$69.4B
$7K ﹤0.01%
85
– –
16 17
18
19 20

Similar funds

FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
JC
JB Capital Wethersfield, Connecticut $2.48B AUM 22.31% 1-Year Est. Return
TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
Q
QVR San Francisco, California $2.49B AUM 48.58% 1-Year Est. Return
SIM
Stratos Investment Management Beachwood, Ohio $2.49B AUM 17.24% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return

Balentine LLC's Q1 2017 Portfolio in Review

As of Q1 2017, Balentine LLC held 621 positions worth $1.02B, up 7.5% from $952M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Balentine LLC's Q1 2017 filing shows 116 new, 174 increased, 62 reduced and 36 closed positions. Its largest new stake was National Commerce Corporation: 20,608 shares worth $754K. The largest sale was Ventas, an estimated $438K.

By sector, the portfolio is most concentrated in Technology at 2.4% of assets, up from 2.1% a quarter earlier, followed by Financials and Consumer Staples.

  • Balentine LLC's largest Q1 2017 buy was National Commerce Corporation: 20,608 shares worth $754K.
  • Balentine LLC added most to iShares MSCI ACWI ETF in Q1 2017, an estimated $9.24M increase.
  • Balentine LLC's biggest Q1 2017 reduction was Idexx Laboratories, cutting an estimated $266K.
  • Balentine LLC fully exited Ventas in Q1 2017, selling an estimated $438K.
  • Balentine LLC's ten largest holdings make up 93% of its $1.02B portfolio in Q1 2017.
  • Balentine LLC opened 116 new positions and closed 36 in Q1 2017.
  • Balentine LLC's portfolio value rose 7.5% quarter-over-quarter to $1.02B.

Based on Balentine LLC's 13F filing for Q1 2017, filed 12 May 2017.